124 related articles for article (PubMed ID: 9440093)
1. Hemodynamic and hormonal changes during erythropoietin therapy in hemodialysis patients.
Lebel M; Kingma I; Grose JH; Langlois S
J Am Soc Nephrol; 1998 Jan; 9(1):97-104. PubMed ID: 9440093
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of recombinant human erythropoietin in predialysis patients.
Portolés J; Torralbo A; Martin P; Rodrigo J; Herrero JA; Barrientos A
Am J Kidney Dis; 1997 Apr; 29(4):541-8. PubMed ID: 9100042
[TBL] [Abstract][Full Text] [Related]
3. Pressor effect of recombinant human erythropoietin: results of ambulatory blood pressure monitoring and home blood pressure measurements.
Imai Y; Sekino H; Fujikura Y; Munakata M; Minami N; Hashimoto J; Sakuma H; Watanabe N; Misawa S; Nishiyama A
Clin Exp Hypertens; 1995 Apr; 17(3):485-506. PubMed ID: 7613524
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human erythropoietin treatment on hemodynamic parameters in continuous ambulatory peritoneal dialysis and hemodialysis patients.
Fernández A; Vega N; Jiménez F; Macía M; Laraudiogoitía E; Hortal L; Perdomo M; Plaza C; Rodríguez JC; Palop L
Am J Nephrol; 1992; 12(4):207-11. PubMed ID: 1481867
[TBL] [Abstract][Full Text] [Related]
5. Body fluid spaces and blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin.
Abraham PA; Opsahl JA; Keshaviah PR; Collins AJ; Whalen JJ; Asinger RW; McLain LA; Hanson G; Davis MG; Halstenson CE
Am J Kidney Dis; 1990 Nov; 16(5):438-46. PubMed ID: 2239934
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients.
Lebel M; Kingma I; Grose JH; Langlois S
Am J Hypertens; 1995 Jun; 8(6):545-51. PubMed ID: 7662237
[TBL] [Abstract][Full Text] [Related]
7. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients.
Frank H; Heusser K; Höffken B; Huber P; Schmieder RE; Schobel HP
Kidney Int; 2004 Aug; 66(2):832-40. PubMed ID: 15253740
[TBL] [Abstract][Full Text] [Related]
8. Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease.
Berns JS; Rudnick MR; Cohen RM; Bower JD; Wood BC
Kidney Int; 1999 Jul; 56(1):253-60. PubMed ID: 10411700
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients.
Hori K; Onoyama K; Iseki K; Fujimi S; Fujishima M
Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091
[TBL] [Abstract][Full Text] [Related]
10. Pressor effect of recombinant human erythropoietin: results of home blood pressure measurements in hemodialysis patients.
Imai Y; Fujikura Y; Minami N; Munakata M; Hashimoto J; Sakuma H; Watanabe N; Nishiyama A; Misawa S; Sekino H
Nihon Jinzo Gakkai Shi; 1994 Jan; 36(1):51-6. PubMed ID: 8107309
[TBL] [Abstract][Full Text] [Related]
11. Effect of erythropoietin treatment on blood pressure and intracellular cation concentrations in maintenance hemodialysis patients.
Okura Y; Oshima T; Yasunobu Y; Amano K; Mori M; Shinozaki K; Kajiyama G
Hypertens Res; 1996 Jun; 19(2):91-5. PubMed ID: 10968201
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of endothelin-1 antagonists on erythropoietin-induced hypertension in renal failure.
Brochu E; Lacasse S; Larivière R; Kingma I; Grose JH; Lebel M
J Am Soc Nephrol; 1999 Jul; 10(7):1440-6. PubMed ID: 10405199
[TBL] [Abstract][Full Text] [Related]
13. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.
Pascual J; Teruel JL; Moya JL; Liaño F; Jiménez-Mena M; Ortuño J
Clin Nephrol; 1991 Jun; 35(6):280-7. PubMed ID: 1831414
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic changes in hemodialyzed patients during treatment with recombinant human erythropoietin.
Teruel JL; Pascual J; Jiménez M; Liaño F; Rivera M; Martínez J; Moya JL; Ortuño J
Nephron; 1991; 58(2):135-7. PubMed ID: 1865967
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis.
Díez JJ; Iglesias P; Sastre J; Aguilera A; Bajo MA; Méndez J; Gómez Pan A; Selgas R
Metabolism; 1999 Feb; 48(2):210-6. PubMed ID: 10024084
[TBL] [Abstract][Full Text] [Related]
17. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men.
Berglund B; Ekblom B
J Intern Med; 1991 Feb; 229(2):125-30. PubMed ID: 1997637
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamics of patients with renal failure treated with recombinant human erythropoietin.
Verbeelen D; Bossuyt A; Smitz J; Herman A; Dratwa M; Jonckheer MH
Clin Nephrol; 1989 Jan; 31(1):6-11. PubMed ID: 2914412
[TBL] [Abstract][Full Text] [Related]
19. Influence of the 6-month anemia therapy with erythropoietin on renal function and some hemodynamic parameters in predialysis patients.
Tomczak-Watras W; Strózecki P; Zuchora Z; Szefer J; Manitius J
Pol Arch Med Wewn; 2009; 119(1-2):45-51. PubMed ID: 19341178
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic changes by recombinant erythropoietin therapy in hemodialyzed patients.
Satoh K; Masuda T; Ikeda Y; Kurokawa S; Kamata K; Kikawada R; Takamoto T; Marumo F
Hypertension; 1990 Mar; 15(3):262-6. PubMed ID: 2303284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
